Repair Biotechnologies nominated as Growth Equity Deal of the Year by Upstate Capital Association
Upstate Capital Association will be hosting their Annual Awards Celebration on December 6 in Rochester, NY
CNYBAC client, Repair Biotechnologies has been nominated in the Growth Equity Deal of the Year category.
Upstate Capital’s Annual Awards celebrate the important work that people are doing in VC + Growth and PE + M&A. Every year, they recognize the people and the companies making impacts in communities across New York.
Repair Biotechnologies is a late-stage preclinical-stage biotech company developing several first-in-class therapies based on their innovative Cholesterol Degrading Platform, a safe and very well tolerated approach to treating the cause of medical conditions that arise due to localized accumulations of excess cholesterol.